Fulgent Genetics (FLGT) Non-Current Deferred Tax Liability (2016 - 2025)
Historic Non-Current Deferred Tax Liability for Fulgent Genetics (FLGT) over the last 5 years, with Q3 2025 value amounting to $7.0 million.
- Fulgent Genetics' Non-Current Deferred Tax Liability rose 454.41% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 454.41%. This contributed to the annual value of $6.4 million for FY2024, which is 1999.5% down from last year.
- Fulgent Genetics' Non-Current Deferred Tax Liability amounted to $7.0 million in Q3 2025, which was up 454.41% from $6.1 million recorded in Q2 2025.
- Over the past 5 years, Fulgent Genetics' Non-Current Deferred Tax Liability peaked at $9.8 million during Q3 2023, and registered a low of $6.1 million during Q2 2025.
- For the 3-year period, Fulgent Genetics' Non-Current Deferred Tax Liability averaged around $7.2 million, with its median value being $6.9 million (2024).
- Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first tumbled by 3151.63% in 2024, then surged by 454.41% in 2025.
- Over the past 3 years, Fulgent Genetics' Non-Current Deferred Tax Liability (Quarter) stood at $8.0 million in 2023, then decreased by 19.99% to $6.4 million in 2024, then grew by 10.52% to $7.0 million in 2025.
- Its Non-Current Deferred Tax Liability was $7.0 million in Q3 2025, compared to $6.1 million in Q2 2025 and $6.2 million in Q1 2025.